ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Turmoil in Texas: Texas Agency Funded $11 Million Grant Without Peer Review; Official Resigns

November 30, 2012

In Brief: DRCA Board Split On Guidelines For CCOP Remains Unresolved; Chop Implementation Talks Starting

December 4, 1981

NCAB Considers Discrimination Against Patients, Minority Rates, Smokeless Tobacco

April 12, 1985

Professional Societies: Three Groups To File brief In Fisher’s Appeal

October 11, 1996

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994

Nelvis Castro To Serve As Acting OCC Chief; HHS Selects ANA President Malone.

January 7, 2000